Ann: Ryoncil Is Now Available For Purchase In The United States, page-216

You sound more like a frustrated bagholder than a rational investor. If your entire bull case rests on “just wait a few months” and insults aimed at skeptics, it says more about your insecurity than your conviction.

Let’s be clear: questioning Mesoblast’s track record is not stupidity, it’s due diligence. This is a company that’s burned hundreds of millions, repeatedly promised approvals that didn’t materialize, and still needs to prove commercial execution — something it’s never done at scale.

As for your praise of Silviu, spare me the revisionist history. He may have finally delivered an approval, but it took over a decade of delays, failed trials, and questionable capital raises. The “treble reimbursement” claim — I’ll wait to see audited revenues, not your back-of-the-envelope bravado.

And don’t talk down to people about short selling when the stock's been in freefall for years. If you're so convinced this is a short squeeze waiting to happen, maybe ask yourself why institutions haven't rushed to buy more.

Sales projections are meaningless until they’re in black and white in a quarterly report. Hype doesn't move markets sustainably — execution does. And throwing tantrums about people not instantly believing in sky-high uptake after 24 hours on market only makes you sound desperate.

So yeah — I’ll keep being skeptical. Not because I’m “frightened,” but because I prefer facts over fanboy fiction. If Ryoncil delivers — great. I’ll be the first to update my view. But until then, you don’t get to yell “how can people be so stupid?” just because some of us expect more than hopium.